Clinical and biochemical manifestations of severe sickle cell anemia in adult patients in steady state in Ile-Ife, Nigeria
Abstract
Background: There are documented established markers (indices) of disease severity in patients with sickle cell anemia (SCA) and they determine the course of the disease. This study investigated the pattern and prevalence of some of these markers of disease severity in adult patients with SCA in steady state attending the hematology clinic of a federal tertiary teaching hospital in Ile-Ife, Nigeria.
Materials and Methods: This was a descriptive study. Basic demographic data and relevant clinical information was obtained using a well-structured questionnaire and the case files (hospital records) of 50 consecutive SCA (HbSS) patients.
Results: The study group comprised of 21(42%) males and 29(58%) females. The age range was 18–45years with a mean(±SD) of 27.6±7.607. Hepatomegaly (64%), frequent episodes of vaso-occlusive crisis, that is, ≥ 3 episodes per year(30%) and Dactylitis in infanthood(26%) were the most common clinical parameters identified in these patients while a high serum total bilirubin of > 51μmol/L(26%) was the most common laboratory parameter seen in these patients.
Conclusion: Markers of disease severity were identified in the patients with SCA in
this study. The presence of these markers in an SCA patient connotes severe disease and they determine the course of the disease. Therefore, there is a need to pay more attention to these patients by following them up more closely.
References
[2] Maakaron, J. E. and Besa, E. C. (2013). Sickle cell anemia. Medscape Reference. Retrieved from: http://www.emedicine.medscape.com/article/205926 (accessed on January 28, 2013).
[3] Beutler, E., Lichtman, M. A., and Coller, B. S. (eds.). (2001). Sickle cell disease, in William Hematology (sixth edition), pp. 581–589. McGraw-Hill.
[4] Hoffbrand, A. V., Catovsky, D., and Tuddenham, E. G. (eds.). (2005). Sickle cell
disease, in Postgraduate Hematology (fifth edition), pp. 104–118. Blackwell.
[5] World Health Organization. (April 24, 2006). 59????ℎ World Health Assembly, Provisional
Agenda Item 11.4, pp. 1-5. Geneva: WHO.
[6] Anie, K. A., Egunjobi, F. E., and Akinyanju, O. O. (2010). Psychosocial impact of sickle
cell disorder: perspectives from a Nigerian setting. Globalization and Health, vol. 6,
pp. 1–6.
[7] Durosinmi, M. A., Odebiyi, A. I., Akinola, N. O., et al. (1997). Acceptability of prenatal
diagnosis of sickle cell anemia by a sample of the Nigerian population. African
Journal of Medicine and Medical Sciences, vol. 26, pp. 55–58.
[8] Halim, N. K., Famodu, A. A., and Wemambu, S. N. (eds.). (2001). Sickle cell disease,
in Textbook of Clinical Hematology and Immunology (second edition), pp. 24–28.
Ambik.
[9] Animasahun, B. A. and Temiye, E. O. (2011). The influence of socio-economic status
on the hemoglobin level and anthropometry of sickle cell anemia patients in steady
state at the Lagos University Teaching Hospital. Nigerian Journal of Clinical Practice,
vol. 14, pp. 422–427.
[10] Sebastiani, P., Nolan, V. G., Baldwin, C. T., et al. (2007). A network model to predict
the risk of death in sickle cell disease. Blood, vol. 110, pp. 2727–2735.
[11] Steinberg, M. H. (2005). Predicting clinical severity in sickle cell anemia. British
Journal of Hematology, vol. 129, pp. 465–481.
[12] Bookchin, R. M. and Lew, V. L. (1996). Pathophysiology of sickle cell anemia.
Hematology/Oncology Clinics of North America, vol. 10, pp. 124–1253.
[13] Xandra, W., Johanna, H., Harriet, H., et al. (2010). Development and validation of a
pediatric severity index for sickle cell patients. American Journal of Hematology,
vol. 85, pp. 746–751.
[14] Banerjee, S., Owen, C., and Chopra, S. (2001). Sickle cell hepatopathy. Hepatology,
vol. 33, pp. 1021–1028.
[15] Olaniyi, J. A. and Abjah, U. M. (2007). Frequency of hepatomegaly and splenomegaly
in Nigerian patients with sickle cell disease. WAJM, vol. 26, pp. 274–277.
[16] Balci, A., Karazincir, S., Sangun, O., et al. (2008). Prevalence of abdominal
ultrasonographic abnormalities in patients with sickle cell disease. Diagnostic and
Interventional Radiology, vol. 14, pp. 133–137.
[17] Papadaki, M. G., Kattamis, A. C., and Papadaki, I. G. (2003). Abdominal
ultrasonographic findings in patients with sickle-cell anemia and thalassaemia
intermedia. Pediatric Radiology, vol. 33, pp. 515–521.
[18] Olatunji, P. O. and Falusi, A. G. (1994). Persistent hepatomegaly: an index of severity
in sickle cell anemia. East African Medical Journal, vol. 71, pp. 742–744.
